Tata Sons-backed Tata Capital files for IPO: All you need to know

In the last six years, Tata Capital has received capital infusion to the tune of ₹6,000 crores, out of which ₹2,000 crore and ₹500 crore was infused during FY24 and FY23, respectively.

Leave a Reply

Your email address will not be published. Required fields are marked *